Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial

Postmenopausal women on aromatase inhibitors (AI) are at risk of aromatase inhibitor-associated bone loss (AIBL) and fractures. In 2005 Osteoporosis Australia proposed an algorithm for bisphosphonate intervention. Three hundred and three postmenopausal women with early breast cancer (EBC) were enrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lomax, Anna J., Yee Yap, Saw, White, Karen, Beith, Jane, Abdi, Ehtesham, Broad, Adam, Sewak, Sanjeev, Lee, Chooi, Sambrook, Philip, Pocock, Nicholas, Henry, Margaret J., Yeow, Elaine G., Bell, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723379/
https://www.ncbi.nlm.nih.gov/pubmed/26909285
http://dx.doi.org/10.1016/j.jbo.2013.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723379/
https://www.ncbi.nlm.nih.gov/pubmed/26909285
http://dx.doi.org/10.1016/j.jbo.2013.08.001

Ejemplares similares